Arian Mossanenzadeh is a partner in the firm’s Executive Compensation Group. His practice involves a wide range of executive compensation matters, primarily advising public and privately held companies in connection with mergers and acquisitions, public offerings and other corporate transactions. He also counsels clients on the drafting and negotiation of incentive compensation arrangements and executive employment and separation agreements, as well as securities and tax law issues pertaining to executive compensation.
Arian’s notable transactions include representing:
- Element Solutions in its $14.5 billion cash-and-stock merger with Solstice Advanced Materials
- Galapagos in a research and development collaboration with Gilead in connection with Gilead’s
$1.675 billion acquisition of Ouro Medicines
- ANV Group Holdings Ltd. in its acquisition of Open Lending Corporation
- General Atlantic, alongside Canada Pension Plan Investment Board, in its strategic investment in Boats Group
- GI Partners in its acquisition of Netwatch from The Riverside Company
- KPS Capital Partners in in a variety of matters, including:
- a controlling interest in Jennmar and its affiliates
- a controlling stake in Novacel from Compagnie Chargeurs Invest
- The Wells Companies
- Laird Superfood and Nexus Capital Management in connection with Laird’s $48 million all-cash acquisition of Terrasoul Superfoods
- Nebius Group in various matters, including:
- its agreement to license AI inference and compute orchestration technology from Clarifai, and to hire Clarifai’s core engineering and research team, including the founder and CEO
- in its approximately $643 million acquisition of Eigen AI
- Zydus Lifesciences Limited in its acquisition of Assertio Holdings
Prior to Paul, Weiss, Arian’s experience includes advising:
- Calpine Corporation in its $17 billion sale to Energy Capital Partners and a consortium of investors
- Cardworks in its acquisition of Ally's credit card business
- Convey Health Solutions in its $1.1 billion take-private acquisition by TPG Capital
- CymaBay Therapeutics in its $4.3 billion acquisition by Gilead Sciences
- The Special Committee of the Board of Directors of EchoStar in the $26 billion combination with DISH Network
- GreenSky in its $2.24 billion acquisition by Goldman Sachs
- HCSC in its $3.3 billion acquisition of Cigna's Medicare businesses and CareAllies
- IBM in multiple transactions including its acquisitions of Accelalpha, Hakkoda and StepZen
- IFM Investors in its $10.3 billion acquisition of Buckeye Partners
- Martin Marietta in its $2.05 billion acquisition of aggregates operations from Blue Water Industries
- New Senior Investment Group in its $2.3 billion acquisition by Ventas
- Panasonic Corp. in its 20% strategic equity investment in Blue Yonder with an estimated enterprise value of $5.5 billion
- Roark Capital Group and Inspire Brands in Inspire Brands’ $2.3 billion acquisition of Sonic Corp.
- SMBC Aviation Capital in its $6.7 billion acquisition of Goshawk Aviation
- WiseTech Global in its $2.1 billion acquisition of e2open
- White Mountains Insurance in its $1.775 billion sale of NSM to Carlyle
